🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in India / NCT06997757
Starting soon Not applicable

Mobile Health on Improving Efficacy of Plaque Control in Antenatal Women With Gingivitis

NCT06997757 · tracked via the Priya Life Science India tracker
Sponsor
Postgraduate Institute of Dental Sciences Rohtak
Phase
Not applicable
Started
2025-06-25
Last updated
2025-05-30

Condition(s) studied

Pregnancy Gingivitis

Investigational drug(s) / intervention(s)

Mobile healthPhase I Therapy

Mobile health: Instructions for brushing twice daily and using interdental cleaning aids via regular mobile phone messages will be sent atleast twice a week.

Phase I Therapy: Instructions for brushing twice daily and using interdental cleaning aids during appointment only.

Study summary

Oral health education, behavioral therapy and counselling to improve home care in pregnant females along with periodontal therapy can be helpful in treating pregnancy associated gingivitis and pregnancy outcomes

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
35 Years
Healthy volunteers
No
Inclusion Criteria: 1. Systemically Healthy pregnant women of age 18-35 years 2. 8-24 weeks of Gestation 3. Generalized gingivitis (BOP score \>30%s, without attachment loss and radiographic bone loss, PPD≤3mm) 4. Access to mobile phone 5. At least 20 natural teeth present Exclusion Criteria: 1. Presence of systemic diseases that could influence the outcome of periodontal therapy (Diabetes mellitus, Hypertension) 2. Smoking/alcohol consumption 3. Patient currently on any antibiotic therapy 4. Risk for Preterm Birth (Delivery \< 37 weeks of gestation) 5. History of periodontal treatment in the last 6 months 6. Physically and mentally impaired patients

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
PGIDS Rohtak Haryana

More Postgraduate Institute of Dental Sciences Rohtak trials in India

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06997757 on ClinicalTrials.gov ↗ ← All trials in India